FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2105330009> ?p ?o ?g. }

• W2105330009 endingPage "629" @default.
• W2105330009 startingPage "621" @default.
• W2105330009 abstract "Novel thiosemicarbazone metal chelators are extensively studied anti-cancer agents with marked and selective activity against a wide variety of cancer cells, as well as human tumor xenografts in mice. This study describes the first validated LC-MS/MS method for the simultaneous quantification of 2-benzoylpyridine 4-ethyl-3-thiosemicarbazone (Bp4eT) and its main metabolites (E/Z isomers of the semicarbazone structure, M1-E and M1-Z, and the amidrazone metabolite, M2) in plasma. Separation was achieved using a C18 column with ammonium formate/acetonitrile mixture as the mobile phase. Plasma samples were treated using solid-phase extraction on 96-well plates. This method was validated over the concentration range of 0.18–2.80 μM for Bp4eT, 0.02–0.37 μM for both M1-E and M1-Z, and 0.10–1.60 μM for M2. This methodology was applied to the analysis of samples from in vivo experiments, allowing for the concentration–time profile to be simultaneously assessed for the parent drug and its metabolites. The current study addresses the lack of knowledge regarding the quantitative analysis of thiosemicarbazone anti-cancer drugs and their metabolites in plasma and provides the first pharmacokinetic data on a lead compound of this class. Copyright © 2013 John Wiley & Sons, Ltd." @default.
• W2105330009 created "2016-06-24" @default.
• W2105330009 creator A5001951129 @default.
• W2105330009 creator A5020959791 @default.
• W2105330009 creator A5045284531 @default.
• W2105330009 creator A5047132165 @default.
• W2105330009 creator A5048968219 @default.
• W2105330009 creator A5051756183 @default.
• W2105330009 creator A5053769968 @default.
• W2105330009 creator A5053826807 @default.
• W2105330009 creator A5061763563 @default.
• W2105330009 creator A5067067361 @default.
• W2105330009 creator A5067324475 @default.
• W2105330009 creator A5070723311 @default.
• W2105330009 creator A5075845989 @default.
• W2105330009 date "2013-11-20" @default.
• W2105330009 modified "2023-10-11" @default.
• W2105330009 title "Simultaneous determination of the novel thiosemicarbazone anti-cancer agent, Bp4eT, and its main phase I metabolites in plasma: Application to a pilot pharmacokinetic study in rats" @default.
• W2105330009 cites W1564930378 @default.
• W2105330009 cites W1964828087 @default.
• W2105330009 cites W1977373583 @default.
• W2105330009 cites W1979685064 @default.
• W2105330009 cites W1994096132 @default.
• W2105330009 cites W2002526053 @default.
• W2105330009 cites W2005154230 @default.
• W2105330009 cites W2010062408 @default.
• W2105330009 cites W2040885378 @default.
• W2105330009 cites W2042218168 @default.
• W2105330009 cites W2051644638 @default.
• W2105330009 cites W2051909399 @default.
• W2105330009 cites W2054565399 @default.
• W2105330009 cites W2070118774 @default.
• W2105330009 cites W2073306905 @default.
• W2105330009 cites W2083315452 @default.
• W2105330009 cites W2089700460 @default.
• W2105330009 cites W2090099202 @default.
• W2105330009 cites W2093729543 @default.
• W2105330009 cites W2114844276 @default.
• W2105330009 cites W2118226539 @default.
• W2105330009 cites W2138364046 @default.
• W2105330009 cites W2152679644 @default.
• W2105330009 cites W2167151742 @default.
• W2105330009 doi "https://doi.org/10.1002/bmc.3080" @default.
• W2105330009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24254882" @default.
• W2105330009 hasPublicationYear "2013" @default.
• W2105330009 type Work @default.
• W2105330009 sameAs 2105330009 @default.
• W2105330009 citedByCount "7" @default.
• W2105330009 countsByYear W21053300092015 @default.
• W2105330009 countsByYear W21053300092016 @default.
• W2105330009 countsByYear W21053300092017 @default.
• W2105330009 countsByYear W21053300092018 @default.
• W2105330009 crossrefType "journal-article" @default.
• W2105330009 hasAuthorship W2105330009A5001951129 @default.
• W2105330009 hasAuthorship W2105330009A5020959791 @default.
• W2105330009 hasAuthorship W2105330009A5045284531 @default.
• W2105330009 hasAuthorship W2105330009A5047132165 @default.
• W2105330009 hasAuthorship W2105330009A5048968219 @default.
• W2105330009 hasAuthorship W2105330009A5051756183 @default.
• W2105330009 hasAuthorship W2105330009A5053769968 @default.
• W2105330009 hasAuthorship W2105330009A5053826807 @default.
• W2105330009 hasAuthorship W2105330009A5061763563 @default.
• W2105330009 hasAuthorship W2105330009A5067067361 @default.
• W2105330009 hasAuthorship W2105330009A5067324475 @default.
• W2105330009 hasAuthorship W2105330009A5070723311 @default.
• W2105330009 hasAuthorship W2105330009A5075845989 @default.
• W2105330009 hasConcept C112705442 @default.
• W2105330009 hasConcept C149151106 @default.
• W2105330009 hasConcept C150903083 @default.
• W2105330009 hasConcept C185592680 @default.
• W2105330009 hasConcept C207001950 @default.
• W2105330009 hasConcept C2775986502 @default.
• W2105330009 hasConcept C2777463227 @default.
• W2105330009 hasConcept C2777477808 @default.
• W2105330009 hasConcept C43617362 @default.
• W2105330009 hasConcept C55493867 @default.
• W2105330009 hasConcept C71240020 @default.
• W2105330009 hasConcept C71924100 @default.
• W2105330009 hasConcept C83591994 @default.
• W2105330009 hasConcept C86803240 @default.
• W2105330009 hasConcept C98274493 @default.
• W2105330009 hasConceptScore W2105330009C112705442 @default.
• W2105330009 hasConceptScore W2105330009C149151106 @default.
• W2105330009 hasConceptScore W2105330009C150903083 @default.
• W2105330009 hasConceptScore W2105330009C185592680 @default.
• W2105330009 hasConceptScore W2105330009C207001950 @default.
• W2105330009 hasConceptScore W2105330009C2775986502 @default.
• W2105330009 hasConceptScore W2105330009C2777463227 @default.
• W2105330009 hasConceptScore W2105330009C2777477808 @default.
• W2105330009 hasConceptScore W2105330009C43617362 @default.
• W2105330009 hasConceptScore W2105330009C55493867 @default.
• W2105330009 hasConceptScore W2105330009C71240020 @default.
• W2105330009 hasConceptScore W2105330009C71924100 @default.
• W2105330009 hasConceptScore W2105330009C83591994 @default.
• W2105330009 hasConceptScore W2105330009C86803240 @default.
• W2105330009 hasConceptScore W2105330009C98274493 @default.
• W2105330009 hasIssue "5" @default.
• W2105330009 hasLocation W21053300091 @default.

• next